Cardiovascular Outcomes in Initial and Sustained Orthostatic Hypotension: A Retrospective Cohort Study

Hui Geng1, Dingfeng Fang1,2, Xiahuan Chen1

  • 1Department of Geriatrics, Peking University First Hospital, Beijing, China.

Insights

Orthostatic hypotension (OH) increases cardiovascular risk in older adults. Initial OH elevates the risk of major adverse cardiovascular events, while sustained OH raises the risk of both cardiovascular events and mortality.

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Research
  • Clinical Epidemiology

Background:

  • Orthostatic hypotension (OH) is a prevalent geriatric condition linked to cardiovascular disease.
  • Limited data exist on the comparative prognostic significance of initial versus sustained OH.
  • Understanding these distinctions is crucial for geriatric cardiovascular risk assessment.

Purpose of the Study:

  • To investigate and compare the cardiovascular outcomes associated with initial and sustained orthostatic hypotension in patients aged 50 years and older.
  • To determine the differential impact of initial and sustained OH on major adverse cardiovascular events (MACE) and all-cause mortality.

Main Methods:

  • A cohort study including 435 participants aged ≥50 years.
  • Diagnosis of initial or sustained OH using an active orthostatic test with the CNAP monitor.
  • Kaplan-Meier survival analysis and multivariable Cox regression models were employed for outcome analysis over a median follow-up of 65 months.

Main Results:

  • Of 435 participants, 94 (21.6%) had initial (43) or sustained (51) OH.
  • The primary outcome (MACE and death) occurred in 159 (36.6%) patients.
  • Initial OH significantly increased the risk of the primary outcome and MACE (HR 2.20 and 2.38, respectively), but not mortality.
  • Sustained OH significantly increased the risk of the primary outcome, MACE (HR 1.77 and 1.71, respectively), and mortality (HR 3.32).

Conclusions:

  • Both initial and sustained orthostatic hypotension increase cardiovascular risk in patients aged ≥50 years.
  • Sustained OH, specifically, is associated with an increased risk of mortality.
  • These findings highlight the importance of differentiating OH types for accurate cardiovascular risk stratification in older adults.

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
729
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
516
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
308